青少年肥胖已成为严峻的公共卫生问题。青少年处于特殊的生理和心理发展阶段，生活方式干预和药物治疗对部分重度肥胖青少年效果有限，外科减重手术效果显著，却存在创伤大、并发症风险高等问题。内镜下减重手术为青少年肥胖治疗提供了微创、可逆、有效的新选择，填补了生活方式干预与外科手术之间的治疗空白。未来青少年内镜减重治疗领域将朝着“精准化”“系统化”“人性化”方向发展，通过多学科协作构建全程管理体系，通过心理支持和家庭参与提升整体健康结局。
Abstract
Adolescent obesity has become a serious public health issue. Adolescents are at a unique stage of physiological and psychological development, where lifestyle interventions and pharmacological treatments show limited effectiveness for some severely obese cases. While bariatric surgery yields significant results, it carries risks such as high invasiveness and potential complications. Endoscopic bariatric therapies offer a minimally invasive, reversible, and effective new option for treating ado-lescent obesity, bridging the gap between lifestyle interventions and surgical procedures. In the future, the field of endoscopic bariatric treatment for adolescents will advance toward greater precision, systematization, and humanization. Through multidis-ciplinary collaboration, a comprehensive management system will be established, while psychological support and family in-volvement will enhance overall health outcomes.
关键词
青少年 /
肥胖 /
内镜 /
减重
Key words
adolescent /
obesity /
endoscope /
bariatric treatment
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
［1］ Apovian CM. Obesity: definition, comorbidities, causes, and burden［J］. Am J Manag Care，2016，22(suppl7):176-185. PMID: 27356115.
［2］ O'Connor EA, Evans CV, Burda BU, et al. Screening for obesity and intervention for weight management in children and adolescents: evidence report and systematic review for the US Preventive Services Task Force［J］. JAMA, 2017, 317(23): 2427-2444. DOI：10.1001/jama.2017.0332.
［3］ Torbahn G, Lischka J, Brown T, et al. Anti-obesity medication in the management of children and adolescents with obesity: Recent developments and research gaps［J］. Clin Endocrinol (Oxf)，2025，102(1): 51-61. DOI：10.1111/cen.15133.
［4］ Di Lorenzo N, Antoniou SA, Batterham RL, et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP［J］. Surg Endosc，2020，34: 2332-2358. DOI：10.1007/s00464-020-07555-y.
［5］ Salminen P, Kow L, Aminian A, Kaplan LM, et al. IFSO consensus on definitions and clinical practice guidelines for obesity management：an international delphi study［J］. Obes Surg，2024，34(1): 30-42. DOI：10.1007/s11695-023-06913-8.
［6］ Calcaterra V, Cena H, Pelizzo G, et al. Bariatric surgery in adolescents: to do or not to do?［J］. Children (Basel)，2021，8（6）：453. DOI：10.3390/children8060453.
［7］ Alqahtani AR, Elahmedi M, Abdurabu HY, et al. Ten-year outcomes of children and adolescents who underwent sleeve gastrectomy: weight loss, comorbidity resolution, adverse events, and growth velocity［J］. J Am Coll Surg，2021，233(6): 657-664. DOI：10.1016/j.jamcollsurg.2021.08.678.
［8］ Shehata M, Abosena W, Elhaddad A, et al. Seven years follow-up after sleeve gastrectomy in adolescents［J］. Obes Surg，2025，35(7): 2680-2688. DOI：10.1007/s11695-025-07966-7.
［9］ Abu Dayyeh B, Kumar N, Edmundowicz SA, et al. ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies［J］. Gastrointest Endosc，2015，82: 425-438. DOI：10.1016/j.gie.2015.03.1964.
［10］ Moura D, Oliveira J, De Moura EGH, et al. Effectiveness of intragastric balloon for obesity: A systematic review and meta- analysis based on randomized control trial［J］. Surg Obes Relat Dis，2016，12: 420-429. DOI：10.1016/j.soard.2015.10.077.
［11］ Ohta M, Maekawa S, Imazu H, et al. Endoscopic intragastric balloon therapy for 15 years in Japan: Results of nationwide surveys［J］. Asian J Endosc Surg，2021，14(3): 401-407. DOI：10.1111/ases.12881.
［12］ Fittipaldi-Fernandez RJ, Guedes MR, Galvao Neto MP, et al. Efficacy of intragastric balloon treatment for adolescent obesity［J］. Obes Surg，2017，27(10):2546-2551. DOI：10.1007/s11695-017-2699-1.
［13］ Oyola C, Berry M, Salazar MAP, et al. Successful weight loss in adolescents with overweight or obesity using a swallowable intragastric balloon and nutritional oversight［J］. Obes Surg，2024，34(10): 3762-3770. DOI：10.1007/s11695-024-07458-0.
［14］ Abu Dayyeh, Barham KAcosta, Andres J，et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): A prospective，multicentre，randomised trial［J］. Lancet，2022，400(10350): 441-451. DOI：10.1016/S0140-6736(22)01280-6.
［15］ Vargas EJ, Rizk M, Gomez-Villa J, et al. Effect of endoscopic sleeve gastroplasty on gastric emptying, motility and hormones: A comparative prospective study［J］. Gut，2023，72(6):1073-1080. DOI：10.1136/gutjnl-2022-327816.
［16］ Alqahtani A, Elahmedi M, Alqahtani YA, et al. Endoscopic sleeve gastroplasty in 109 consecutive children and adolescents with obesity: Two-year outcomes of a new modality［J］. Am J Gastroenterol，2019，114(12): 1857-1862. DOI：10.14309/ajg.0000000000000440.
［17］ Chen W, Feng J, Dong S, et al. Efficacy and safety of duodenal-jejunal bypass liner for obesity and type 2 diabetes: A systematic review and meta-analysis［J］. Obes Rev，2024，25(11): e13812. DOI：10.1111/obr.13812.
［18］ 周艳华, 张倩, 张澍田, 等. 内镜下胃转流支架系统治疗肥胖的疗效和安全性分析［J］. 中华消化内镜杂志, 2024, 41(1)：18-24. DOI: 10.3760/cma.j.cn321463-20230912-00377.
［19］ 王存川，周福庆，董志勇. 国际减重与代谢外科最新动态和评价［J］. 中国实用外科杂志, 2023, 43(5):503-509. DOI：10.19538/j.cjps.issn1005-2208.2023.05.05.
